China Bird Flu Death Roll 20, Total H7N9 Cases 102, WHO Experts Visiting Shanghai and Beijing

April 22, 2013 Leave a comment

China Bird Flu Death Roll 20, Total H7N9 Cases 102, WHO Experts Visiting Shanghai and Beijing

Apr 21, 2013 09:14 PM EDT    | Staff Reporter

China confirmed six more cases of H7N9 human avian influenza during last 24 hour period ending at 4.p.m on Sunday April 21. Five new cases in Zhejiang and one in Jiangsu. The National Health and Family Planning Commission counted total of 102 H7N9 cases in China and 20 cases that led to death.70 H7N9 patients are still being treated in designated hospitals, reported the commission in its daily report while 12 H7N9 patients were discharged from the hospitals. The commission confirmed that all H7N9 cases are isolated and there was no sign of human-to-human transmission.

A summary where the cases appeared:
– 33 cases were reported in Shanghai and 11 among them led to death
– 24 cases were reported in Jiangsu Province and three among them led to death
– 38 cases were reported in Zhejiang Province and five among them led to death
– 3 cases were reported in Anhui Province and one among them led to death.
– 3 cases were reported Henan Province
– 1 case was reported in Beijing

On Friday, April 19, WHO experts arrived in China to assess areas affected by H7N9 in Shanghai and Beijing. They will stay on the mission for a week.

Glenn Thomas, WHO spokesperson confirmed that 15 people are on this team, including international and Chinese experts in epidemiology, laboratories, clinical management and other areas. The team plans to visit many sites in Shanghai and Beijing, observe the situation and give recommendations on how to prevent and control this deadly disease. The team also wants to find answers on the source of the virus, family clusters cases and the ways of transmission.

Thomas said that the reason to choose Shanghai was that it was the core area of the outbreak. Beijing was chosen as a place for further discussions and summaries.

Filed under Health

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment